# Longitudinal Characterization of Males With X-Linked Creatine Transporter Deficiency: Final Results of a Multiyear Observational Study

**Authors:** Judith S. Miller, Cristan Farmer, Susan Blair, Simona Bianconi, Natacha Akshoomoff, Irina Anselm, Bruce A. Barshop, Lindsey Becker, Amanda E. Bennett, Leandra N. Berry, Elizabeth M. Berry-Kravis, Aleksandra Bruchey, Anna W. Byars, Tricia Cimms, Kim M. Cecil, Maxine Covello, Laura S. Cubit, Tanvi Das, Robert J. Davis, Madison Drye, Can Ficicioglu, John B. Fulton, Robin P. Goin-Kochel, Whitney Guthrie, Barbara E. Hallinan, Fady Hannah-Shmouni, Kathryn E. Gustafson, Dwight D. Koeberl, Nicola Longo, Eva Mamak, Saadet Mercimek-Andrews, Claire Michalak, Forbes D. Porter, Samar Rahhal, Linda Rees, Gail A. Spiridigliozzi, Caitlin Stone, Nancy R. Sullivan, V. Reid Sutton, Rebecca P. Thomas, Manisha Udhnani, Susan Waisbren, Michelle Xu, Lin Zhang, Melanie Brandabur, Audrey Thurm

PMC · DOI: 10.1016/j.pediatrneurol.2025.10.023 · Pediatric neurology · 2026-02-14

## TL;DR

This study tracked the development of males with a genetic disorder affecting creatine transport, finding persistent intellectual disability but some skill development over time.

## Contribution

The study provides longitudinal data on CTD's developmental trajectory using absolute metrics to quantify skill development.

## Key findings

- Participants showed significant intellectual disabilities and limited skill development over time.
- Most participants had seizures, gastrointestinal issues, and growth failure.
- Developmental gains were slower than average, especially in older participants.

## Abstract

The purpose of the Vigilan observational study (ClinicalTrials.gov, NCT02931682) was to prospectively assess the natural history and developmental course of creatine transporter deficiency (CTD).

Males with CTD aged 6 months to 65 years were evaluated at 6-month intervals for up to 4 years. Evaluations included neurodevelopmental assessments of intellectual functioning, adaptive functioning, and challenging behaviors and the onset and progression of medical comorbidities.

Fifty participants (median age, 7.6 years) were enrolled. The predominant CTD phenotype consisted of significant intellectual disabilities and limited skill development over time. Most participants had a history of febrile or nonfebrile seizures, gastrointestinal symptoms, and growth failure. All participants learned how to walk, 78% developed at least some verbal speech, and 34% communicated using phrases or sentences. Norm-referenced neurodevelopment assessments indicated declining standardized scores over time; however, absolute scores (i.e., age equivalent person ability scores) indicated that developmental gains were slower than average, particularly among older participants. Between-person differences in neurodevelopmental skills as a function of age did not match within-person change, suggesting a cohort effect.

In this cohort, CTD was associated with significant and persistent intellectual disability. The use of absolute metrics from neurodevelopmental tests (e.g., person ability scores) allowed for the quantification of slow, but present, skill development.

## Linked entities

- **Diseases:** creatine transporter deficiency (MONDO:0010305)

## Full-text entities

- **Diseases:** growth failure (MESH:D051437), gastrointestinal symptoms (MESH:D012817), intellectual disabilities (MESH:D008607), seizures (MESH:D012640), CTD (MESH:C535598)

## Full text

_Full body text omitted from this summary view._ Fetch the complete paper as Markdown: https://tomesphere.com/paper/PMC12905711/full.md

## Figures

3 figures with captions in the complete paper: https://tomesphere.com/paper/PMC12905711/full.md

## References

39 references — full list in the complete paper: https://tomesphere.com/paper/PMC12905711/full.md

---
Source: https://tomesphere.com/paper/PMC12905711